1 Min Read
March 20 (Reuters) - Piramal Enterprises Ltd:
* Piramal Enterprises completes acquisition of a portfolio of drugs for spasticity and pain management from Mallinckrodt LLC Source text: (bit.ly/2n55MD8) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.